Hao-Cheng Lin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The Immunoscore was initially established to evaluate the prognosis of stage I/II/III colorectal cancer patients. However, the feasibility of the Immunoscore for the prognosis of colorectal cancer liver metastases (CRCLM) has not been reported. Liver metastases in 249 CRCLM patients were retrospectively analyzed. The Immunoscore was assessed according to(More)
BACKGROUND Pathologic response is evaluated according to the extent of tumor regression and is used to estimate the efficacy of preoperative treatment. Several studies have reported the association between the pathologic response and clinical outcomes of colorectal cancer patients with liver metastases who underwent hepatectomy. However, to date, no data(More)
  • 1